Biochemical pharmacology of platelet-activating factor (and PAF antagonists) in relation to clinical and experimental thrombocytopenia.
Meade
C J
CJ
Department of Pharmacology, Boehringer Ingelheim KG, Federal Republic of Germany.
Heuer
H
H
Kempe
R
R
D000818:Animals; D001792:Blood Platelets / Q000187:drug effects; D006801:Humans; D010972:Platelet Activating Factor / Q000037:antagonists & inhibitors / Q000494:pharmacology* / Q000633:toxicity; D010976:Platelet Count; D010980:Platelet Membrane Glycoproteins; D011696:Purpura, Thrombocytopenic / Q000209:etiology; D011956:Receptors, Cell Surface / Q000037:antagonists & inhibitors*; D043562:Receptors, G-Protein-Coupled; D013921:Thrombocytopenia / Q000209:etiology* / Q000628:therapy
D010972:Platelet Activating Factor; D010980:Platelet Membrane Glycoproteins; D011956:Receptors, Cell Surface; D043562:Receptors, G-Protein-Coupled; C039351:platelet activating factor receptor